Connect with us

Health

Randox Unveils SARS-CoV-2 Antibody Test to Determine Previous COVID-19 Infection in Just 1.5 Hours – HospiMedica

Randox Laboratories (Crumlin, UK) has launched its new SARS-CoV-2 IgG test, utilizing patented Randox Biochip Technology to simultaneously detect IgG antibodies…

Published

on

post featured image

Randox Laboratories (Crumlin, UK) has launched its new SARS-CoV-2 IgG test, utilizing patented Randox Biochip Technology to simultaneously detect IgG antibodies that are reactive to both of the leading COVID-19 diagnostic antigens – Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP).Maximum test sensitivity is ensured through simultaneous detection of both RBD-only and NP-only responders, making it superior to current commercially available COVID-19 IgG tests that are based on RBD…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending